piwil1 Antibody

What is PIWIL1 and what is its primary biological function?

PIWIL1 (also known as HIWI or MIWI) is an endoribonuclease that plays a central role in postnatal germ cells by repressing transposable elements and preventing their mobilization, which is essential for germline integrity . It acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins, governing the methylation and subsequent repression of transposons . PIWIL1 directly binds methylated piRNAs, which are 24-30 nucleotide RNAs generated by a Dicer-independent mechanism primarily derived from transposons and other repeated sequence elements .

Beyond transposon silencing, PIWIL1 has additional functions:

• Acts as a component of RISC complexes mediating RNA cleavage and translational silencing

• Plays a role in chromatoid body formation

• Required for stability of some miRNAs

• Sequesters RNF8 in the cytoplasm until late spermatogenesis

How do PIWIL1 protein-piRNA complexes regulate gene expression?

PIWIL1 complexes with piRNAs to form functional units that regulate gene expression through multiple mechanisms:

• Transposon silencing: PIWIL1-piRNA complexes recognize and cleave transposon messenger RNAs, displaying strong preference for uridine in the first position of their guide (g1U preference) .

• mRNA regulation: Beyond transposon silencing, PIWIL1-piRNA complexes target specific mRNAs. Research in lung cancer cells has shown that PIWIL1 complexes may target tumor suppressor genes like PTEN and p53, as well as apoptosis-inducing genes like BAD and CASP3 .

• Translational regulation: PIWIL1-piRNA complexes likely regulate translation during meiosis, affecting protein synthesis of specific targets .

• Epigenetic modification: These complexes direct methylation-based silencing of transposons, contributing to epigenetic regulation .

Methodologically, researchers can identify PIWIL1-targeted mRNAs through co-immunoprecipitation of PIWIL1 protein complexes followed by RNA sequencing, as demonstrated in lung cancer cell studies .

What experimental approaches are most effective for studying PIWIL1-piRNA interactions in research models?

When investigating PIWIL1-piRNA interactions, several methodological approaches have proven successful:

• Co-immunoprecipitation coupled with RNA sequencing:

  • Prepare cell lysates under non-denaturing conditions

  • Use specific PIWIL1 antibodies (such as PIWIL1 2C12 monoclonal antibody) for immunoprecipitation

  • Isolate RNA from the precipitated PIWIL1 protein complex

  • Perform RNA deep sequencing and bioinformatic analysis

• Western blot analysis for protein expression:

  • Optimal dilution: 1:500-1:1000 for PIWIL1 antibodies

  • Most reliable tissue sources: human and mouse testis tissues

• Immunohistochemistry for tissue localization:

  • Recommended antigen retrieval: TE buffer pH 9.0 or citrate buffer pH 6.0

  • Validated in: human testis tissue, human liver cancer tissue, human prostate cancer tissue

• Immunofluorescence for subcellular localization:

  • Validated in mouse testis tissue and HepG2 cells

These techniques allow researchers to identify PIWIL1-piRNA targets and characterize their functional relevance in various biological contexts.

How can researchers differentiate between direct and indirect targets of PIWIL1-mediated regulation?

Distinguishing direct from indirect PIWIL1 targets requires a multi-faceted experimental approach:

• Direct PIWIL1-RNA binding assessment:

  • CLIP-seq (Cross-linking immunoprecipitation followed by sequencing) to identify direct RNA binding sites of PIWIL1

  • PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced CLIP) for enhanced resolution of binding sites

  • RIP-seq (RNA immunoprecipitation sequencing) as demonstrated in the H1299 lung cancer cell model

• Functional validation:

  • Targeted mutation of predicted PIWIL1 binding sites in candidate mRNAs

  • PIWIL1 knockdown/overexpression followed by assessment of candidate mRNA levels

  • In vitro RNA cleavage assays to demonstrate direct cleavage activity

• Computational analysis:

  • Sequence motif analysis to identify common binding patterns

  • Integration with piRNA databases to identify potential guiding piRNAs

  • Correlation analysis between PIWIL1 levels and target expression across multiple samples

For example, the study of PIWIL1 in lung cancer cells utilized differential expression analysis with stringent parameters (fold-change threshold of 2.0, maximum p-value of 0.05, and minimum 1CPM) to identify over 5,505 differentially expressed genes when comparing RASSF1C-overexpressing cells to controls .

What is the specific role of PIWIL1 in spermatogenesis and germline development?

PIWIL1 plays essential roles in spermatogenesis and germline maintenance through several mechanisms:

• Transposon silencing: PIWIL1 is crucial for repressing transposable elements in postnatal germ cells, preventing genome instability during spermatogenesis .

• Chromatoid body formation: PIWIL1 contributes to the formation of chromatoid bodies—specialized RNA processing centers in male germ cells—regulating post-transcriptional gene expression during spermatogenesis .

• RNF8 sequestration: PIWIL1 sequesters RNF8 in the cytoplasm until late spermatogenesis. RNF8 is released upon ubiquitination and degradation of PIWIL1, ensuring proper timing of developmental events .

• miRNA stability regulation: PIWIL1 is required for the stability of specific miRNAs during spermatogenesis, influencing the post-transcriptional regulatory landscape .

Methodologically, studying PIWIL1 in spermatogenesis typically employs immunohistochemistry of testis sections with specific antigen retrieval techniques (TE buffer pH 9.0 or citrate buffer pH 6.0) and Western blot analysis of testicular extracts with 1:500-1:1000 antibody dilutions .

What techniques are optimal for visualizing PIWIL1 localization during different stages of spermatogenesis?

Visualizing PIWIL1 during spermatogenesis requires stage-specific approaches:

• Immunohistochemistry (IHC):

  • Fixation: 4% paraformaldehyde or Bouin's solution for testis tissue

  • Antigen retrieval: TE buffer pH 9.0 (recommended) or citrate buffer pH 6.0

  • PIWIL1 antibody concentration: Typically 1:100-1:500 dilution depending on antibody sensitivity

  • Detection: DAB (3,3'-Diaminobenzidine) visualization with hematoxylin counterstaining

• Immunofluorescence (IF):

  • Validated in mouse testis tissue for stage-specific expression patterns

  • Co-staining with stage-specific markers (e.g., SYCP3 for meiotic stages)

  • Nuclear counterstaining with DAPI to identify specific cell types

• Electron microscopy:

  • Immunogold labeling for ultrastructural localization

  • Particularly useful for studying PIWIL1 in chromatoid bodies

• In situ hybridization combined with IF:

  • For simultaneous detection of PIWIL1 protein and associated piRNAs

  • Enables visualization of functional PIWIL1-piRNA complexes

When interpreting results, researchers should note that PIWIL1 expression varies dramatically across spermatogenic stages and subcellular localization shifts from predominantly cytoplasmic to nuage structures during specific developmental windows.

How does PIWIL1 potentially contribute to cancer development and progression?

Research indicates PIWIL1 may contribute to oncogenesis through several mechanisms:

• Suppression of tumor suppressors: The RASSF1C-PIWIL1-piRNA pathway has been shown to downregulate tumor suppressor genes, including PTEN and p53, potentially promoting cancer cell survival and proliferation .

• Anti-apoptotic effects: PIWIL1 complexes may target apoptosis-inducing genes such as BAD and CASP3, reducing cancer cell death and enhancing tumor growth .

• Transposon silencing dysregulation: Aberrant PIWIL1 expression might disrupt normal transposon silencing, potentially leading to genomic instability that contributes to cancer development.

• Developmental regulation: Isoform 3 of PIWIL1 may function as a negative developmental regulator, and its dysregulation could affect cell differentiation pathways relevant to cancer .

Research has specifically implicated PIWIL1 in lung cancer progression through the RASSF1C-PIWI-piRNA pathway, which promotes expression of PIWIL1 and associated piRNAs in non-small cell lung cancer (NSCLC) cells . Methodologically, researchers identified over 5,505 differentially expressed genes in RASSF1C-overexpressing H1299 lung cancer cells, with significant downregulation of tumor suppressors and apoptotic genes .

What are the best experimental protocols for studying PIWIL1 in cancer tissues and cell lines?

When investigating PIWIL1 in cancer contexts, the following protocols have proven effective:

• PIWIL1 protein detection:

  • Western blot: 1:500-1:1000 antibody dilution for protein extracts from cancer cell lines

  • Immunohistochemistry: Validated in human liver and prostate cancer tissues with TE buffer pH 9.0 for antigen retrieval

  • Immunofluorescence: Successfully used in HepG2 hepatocellular carcinoma cells

• PIWIL1-piRNA complex isolation:

  • Non-denaturing cell lysis conditions

  • PIWIL1 immunoprecipitation using monoclonal antibodies

  • RNA isolation from immunoprecipitates for downstream analysis

• Target identification:

  • RNA sequencing of PIWIL1-associated RNAs

  • Differential expression analysis with fold-change threshold of 2.0, maximum p-value of 0.05, and minimum 1CPM

  • Pathway analysis of identified targets

• Functional analysis:

  • PIWIL1 overexpression in cancer cell models

  • PIWIL1 knockdown through siRNA or CRISPR/Cas9

  • Assessment of proliferation, migration, invasion, and apoptosis

The H1299 non-small cell lung cancer cell line has been validated as an effective model for studying PIWIL1 function in cancer, particularly when manipulating RASSF1C expression to modulate the PIWIL1-piRNA pathway .

What criteria should researchers consider when selecting a PIWIL1 antibody for specific applications?

When selecting a PIWIL1 antibody, researchers should consider these application-specific criteria:

Additional considerations include:

• Epitope region: Antibodies targeting different regions of PIWIL1:

  • N-terminal region (aa 50-150)

  • Central region (aa 390-690)

• Specificity controls:

  • Testing in PIWIL1 knockout/knockdown samples

  • Peptide competition assays

  • Comparison with alternative PIWIL1 antibody clones

• Species reactivity: Ensure the antibody recognizes PIWIL1 in your species of interest, as validated antibodies exist for human, mouse, and rat PIWIL1 .

What are the optimal protocols for co-immunoprecipitation of PIWIL1-associated RNAs?

For successful co-immunoprecipitation of PIWIL1-associated RNAs, the following optimized protocol has been validated:

• Cell/tissue preparation:

  • Prepare cell lysates under non-denaturing conditions

  • For tissue samples (e.g., testis), use gentle mechanical disruption in lysis buffer

  • Use 1 mg of total protein for immunoprecipitation

• Immunoprecipitation:

  • Utilize specific PIWIL1 antibodies (e.g., PIWIL1 2C12 monoclonal antibody)

  • Pre-clear lysates with protein A/G beads

  • Incubate lysates with antibody (typically 2-5 μg) overnight at 4°C

  • Capture antibody-protein complexes with protein A/G beads

• RNA isolation from PIWIL1 complexes:

  • Use commercial RNA isolation kits (e.g., Qiagen)

  • Include RNase inhibitors throughout the procedure

  • Consider crosslinking approaches for transient interactions

• RNA analysis:

  • RNA sequencing for comprehensive profiling

  • RT-qPCR for validation of specific targets

  • Small RNA sequencing for piRNA identification

Critical controls include:

• IgG control immunoprecipitation

• Input sample preservation (10% of starting material)

• RNA quality assessment before sequencing

This approach has been successfully employed to identify over 5,505 differentially expressed genes in RASSF1C-overexpressing lung cancer cells compared to vector controls, revealing potential PIWIL1 targets involved in tumor suppression and apoptosis regulation .

How is PIWIL1 being investigated in contexts beyond germline and cancer?

While PIWIL1 has been primarily studied in germline development and cancer, emerging research is expanding its investigation into new areas:

• Prostate epithelium and vitamin D: Recent research has detected high levels of PIWI-interacting RNAs in the small RNA landscape of prostate epithelium from vitamin D clinical trial specimens, suggesting potential roles for PIWIL1-piRNA pathways in prostate biology and vitamin D response .

• RNA regulatory networks: PIWIL1's role in RNA cleavage and translational silencing suggests broader functions in general RNA regulatory networks beyond transposon control .

• Developmental regulation: Isoform 3 of PIWIL1 may function as a negative developmental regulator, implying roles in cellular differentiation pathways beyond germline tissues .

• miRNA stability: PIWIL1's requirement for certain miRNAs' stability suggests broader roles in small RNA biology and potential applications in RNA therapeutics research .

These emerging directions require interdisciplinary approaches combining molecular biology, developmental biology, and computational analysis to fully elucidate PIWIL1's expanded functional repertoire beyond its canonical roles.

What methodological advances are improving our ability to study PIWIL1-piRNA interactions?

Recent methodological advances enhancing PIWIL1-piRNA research include:

• Advanced RNA sequencing techniques:

  • Single-cell small RNA sequencing for cell-specific piRNA profiles

  • Nanopore direct RNA sequencing for detection of RNA modifications

  • Spatial transcriptomics for localized PIWIL1-piRNA activity mapping

• Improved immunoprecipitation approaches:

  • CLIP-seq variants with enhanced sensitivity for RNA-protein interactions

  • Proximity labeling techniques (BioID, APEX) to identify PIWIL1 interactomes

  • Mass spectrometry integration for comprehensive protein complex identification

• Advanced imaging:

  • Super-resolution microscopy for visualization of piRNA processing bodies

  • Live-cell imaging with fluorescently tagged PIWIL1

  • Expansion microscopy for enhanced visualization of subcellular structures

• Computational tools:

  • Machine learning approaches for piRNA target prediction

  • Integrative multi-omics analysis platforms

  • Enhanced piRNA databases with predicted functional annotations

• CRISPR-based techniques:

  • Precise genome editing of PIWIL1 functional domains

  • CRISPRi/CRISPRa for modulating PIWIL1 expression

  • CRISPR screens to identify novel PIWIL1 pathway components

These methodological advances are expanding our understanding of PIWIL1-piRNA biology by providing higher resolution, more comprehensive data about these complexes and their functions in diverse cellular contexts.